Suppr超能文献

莫西沙星和伏立康唑在猪眼角膜内皮细胞角膜储存介质中的安全性。

Safety of moxifloxacin and voriconazole in corneal storage media on porcine corneal endothelial cells.

机构信息

Department of Ophthalmology and Visual Science, College of Medicine, The Catholic University of Korea , Seoul, Korea.

出版信息

J Ocul Pharmacol Ther. 2010 Aug;26(4):315-8. doi: 10.1089/jop.2009.0136.

Abstract

PURPOSE

The aim of this study was to evaluate the safety of moxifloxacin and voriconazole as a supplement in corneal storage media for porcine corneal endothelial cells.

METHODS

Twenty-eight eyes were divided into 4 groups. In the control group (the C group), corneal buttons were stored for 3 days in Optisol-GS. In the treatment group, the corneal buttons were preserved for 3 days in Optisol-GS mixed with 250 microg/mL moxifloxacin (M group), 100 microg/mL voriconazole (V group), and 250 microg/mL moxifloxacin plus 100 microg/mL voriconazole (MV group). We evaluated the samples via specular microscopy before and after 3 days of preservation. The mean changes of endothelial cell counts were compared among the 4 groups. Scanning electron microscopy was conducted after 3 days of preservation.

RESULTS

Before the preservation, the endothelial cell counts did not differ among the 4 groups (P > 0.05). After 3 days of preservation, the endothelial cell count in the MV group was the lowest among the 4 groups (P < 0.05). After 3 days of preservation, the rate of corneal endothelial cell loss in the M and V groups did not differ significantly from the control group (P > 0.05). The rate of endothelial cell loss in the MV group was significantly higher than that of the control group (P < 0.05). Scanning electron microscopy revealed a normal mosaic pattern for the C, V, and F groups, but hexagonality was not preserved in the MV group.

CONCLUSION

Preservation in Optisol-GS mixed with moxifloxacin (250 microg/mL) plus voriconazole (100 microg/mL) induced significant toxicity on the endothelial cells in porcine corneas, when compared with the control group.

摘要

目的

本研究旨在评估莫西沙星和伏立康唑作为猪眼角膜内皮细胞角膜储存液添加剂的安全性。

方法

28 只眼分为 4 组。在对照组(C 组)中,角膜瓣在 Optisol-GS 中储存 3 天。在治疗组中,角膜瓣在 Optisol-GS 中保存 3 天,其中加入 250μg/ml 莫西沙星(M 组)、100μg/ml 伏立康唑(V 组)和 250μg/ml 莫西沙星加 100μg/ml 伏立康唑(MV 组)。我们在保存前和保存 3 天后通过共焦显微镜评估样本。比较 4 组内皮细胞计数的平均变化。保存 3 天后进行扫描电镜检查。

结果

保存前,4 组间内皮细胞计数无差异(P > 0.05)。保存 3 天后,MV 组内皮细胞计数最低(P < 0.05)。保存 3 天后,M 组和 V 组角膜内皮细胞丢失率与对照组无显著差异(P > 0.05)。MV 组内皮细胞丢失率明显高于对照组(P < 0.05)。扫描电镜显示 C、V 和 F 组的正常镶嵌模式,但 MV 组的六边形结构未被保留。

结论

与对照组相比,Optisol-GS 中混合莫西沙星(250μg/ml)加伏立康唑(100μg/ml)保存会对角膜内皮细胞产生明显毒性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验